Literature DB >> 19166864

Switching between abstract rules reflects disease severity but not dopaminergic status in Parkinson's disease.

Angie A Kehagia1, Roshan Cools, Roger A Barker, Trevor W Robbins.   

Abstract

This study sought to disambiguate the impact of Parkinson's disease (PD) on cognitive control as indexed by task set switching, by addressing discrepancies in the literature pertaining to disease severity and paradigm heterogeneity. A task set is governed by a rule that determines how relevant stimuli (stimulus set) map onto specific responses (response set). Task set switching may entail reconfiguration in either or both of these components. Although previous studies have shown that PD patients are impaired at switching between stimuli, in the present study not all patients were impaired at switching entire task sets, that is, both stimulus and response sets: compared with controls, patients with unilateral signs (Hoehn & Yahr Stage I) demonstrated intact switching, even following withdrawal from dopaminergic medication, while bilaterally affected Stage II patients were impaired. The parametric measure of Unified Parkinson's Disease Rating Scale (UPDRS) score predicted increasing switch costs within the patient group. These findings suggest that switching entire task sets may be a function of extrastriatal, possibly non-dopaminergic pathology which increases as the disease progresses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19166864     DOI: 10.1016/j.neuropsychologia.2009.01.002

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  19 in total

1.  Striatal dopamine influences the default mode network to affect shifting between object features.

Authors:  Linh C Dang; Aneesh Donde; Cindee Madison; James P O'Neil; William J Jagust
Journal:  J Cogn Neurosci       Date:  2012-05-29       Impact factor: 3.225

Review 2.  Human category learning 2.0.

Authors:  F Gregory Ashby; W Todd Maddox
Journal:  Ann N Y Acad Sci       Date:  2010-12-23       Impact factor: 5.691

3.  The relation of anxiety and cognition in Parkinson's disease.

Authors:  Gretchen O Reynolds; Kristine K Hanna; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Neuropsychology       Date:  2017-04-20       Impact factor: 3.295

4.  Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson's disease.

Authors:  Ji Hyun Ko; Francesca Antonelli; Oury Monchi; Nicola Ray; Pablo Rusjan; Sylvain Houle; Anthony E Lang; Leigh Christopher; Antonio P Strafella
Journal:  Hum Brain Mapp       Date:  2012-02-14       Impact factor: 5.038

5.  Frontostriatal involvement in task switching depends on genetic differences in d2 receptor density.

Authors:  Christine Stelzel; Ulrike Basten; Christian Montag; Martin Reuter; Christian J Fiebach
Journal:  J Neurosci       Date:  2010-10-20       Impact factor: 6.167

6.  Partial lesion of the nigrostriatal dopamine pathway in rats impairs egocentric learning but not spatial learning or behavioral flexibility.

Authors:  Katharine M Seip-Cammack; James J Young; Megan E Young; Matthew L Shapiro
Journal:  Behav Neurosci       Date:  2017-02-20       Impact factor: 1.912

7.  Rule-based categorization deficits in focal basal ganglia lesion and Parkinson's disease patients.

Authors:  Shawn W Ell; Andrea Weinstein; Richard B Ivry
Journal:  Neuropsychologia       Date:  2010-06-17       Impact factor: 3.139

8.  Levodopa and the feedback process on set-shifting in Parkinson's disease.

Authors:  Wing Lok Au; Juan Zhou; Paulito Palmes; Yih-Yian Sitoh; Louis Cs Tan; Jagath C Rajapakse
Journal:  Hum Brain Mapp       Date:  2011-03-24       Impact factor: 5.038

9.  Dissociable fronto-striatal effects of dopamine D2 receptor stimulation on cognitive versus motor flexibility.

Authors:  Christine Stelzel; Christian J Fiebach; Roshan Cools; Sharwin Tafazoli; Mark D'Esposito
Journal:  Cortex       Date:  2013-04-11       Impact factor: 4.027

10.  Stimulation of contacts in ventral but not dorsal subthalamic nucleus normalizes response switching in Parkinson's disease.

Authors:  Ian Greenhouse; Sherrie Gould; Melissa Houser; Adam R Aron
Journal:  Neuropsychologia       Date:  2013-04-02       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.